Kenek PIERS

Risk assessment of complications of hypertension in pregnancy

Advanced Decision Support Technology

Kenek PIERS is a first-of-its-kind decision support aid intended for clinicians that incorporates the most advanced predictive risk assessment algorithms ever developed. The PIERS algorithms have been extensively validated and have been deployed at unprecedented scale - over 70,000 subjects in four countries. Kenek PIERS represents a critical advance for clinical triage and monitoring, and use in front-line healthcare for preeclampsia globally.

The Kenek PIERS  Preeclampsia Risk Assessment solution is an app that works with most Android tablets. It supports clinicians and paramedical personnel through a validated process of assessment of the risk of maternal complications related to hypertensive disorders of pregnancy for diagnosed patients. Kenek PIERS utilizes the validated PIERS (Pre-eclampsia Integrated Estimate of RiSk) assessment algorithms and widely utilized in the CLIP trials (Community-Level Interventions for Pre-eclampsia) of the Gates Foundation funded PRE-EMPT initiative and PRECISE (PREgnancy Care Integrating translational Science, Everywhere) project. The trials will complete in early 2018.

The Kenek PIERS tablet-based app is intended for use in three primary environments:

  • Professional Healthcare Office environment to be used by trained Health Care Professionals
  • Paramedical operators such as nurses or health technicians in primary care or remote clinics
  • Investigative studies in clinical, remote and field environments

This product is a data collection and analysis tool that provides decision support for healthcare professionals. It is not for home use by patients. It does not directly measure the patient’s vital signs, symptoms or other physiological data. It requires use of separate vital signs monitors for blood oxygen, blood pressure, and proteinuria.

Features:

  • Risk estimation calculation for patients diagnosed with hypertension disorders of pregnancy
  • Fully validated PIERS models
  • Clinical assessment process support
  • Account management for users and patients
  • Monitors validity of patient data
  • Saves patient data and risk assessments
  • Exports saved results in anonymized format
  • Language localized for English and Portuguese

This product may be used on women at the gestational age of 20 weeks or more. It should be operated by a healthcare professional with the appropriate training.

Looking for international availability or other languages?  Kenek PIERS  is available only from LionsGate Technologies - contact us for more information at contact@LGTmedical.com.  

Supported Devices
  • Android 4.4 and later
  • Tablets with 1280x800 resolution
  • Recommended 2G memory, 16G storage

The Kenek PIERS Preeclampsia Risk Assessment App is currently available for pilots and research studies. It is intended for healthcare professionals who have been trained in its use. It is not a medical device. The Kenek PIERS app, and the fullPIERS and miniPIERS algorithms are exclusively licensed to LionsGate Technologies and may not be re-used or resold without sub-license in any form or derivative.

Contact LionsGate Technologies at contact@LGThealth.com for more information.

The hypertensive disorders of pregnancy (HDP) complicate 5-10% of pregnancies and lead to serious maternal illness or death.

Pre-eclampsia is the most serious of these disorders and worldwide is the second leading cause of maternal death, and results in 60,000-80,000 maternal deaths each year.

World Health Organization Fact Sheet, May 2012